BIO Praises the U.S. House of Representatives for Passing the Pandemic and All-Hazards Preparedness Reauthorization ActMar 5 2013
On March 4, 2013, the U.S. House of Representatives passed PAHPRA by a vote of 370-28.
|
|
2013 BIO International Convention Super Sessions to Highlight State of the Industry, Global Innovation and the Affordable Care ActMar 4 2013
The 2013 BIO International Convention will feature six diverse Super Sessions highlighting pressing industry topics such as the state of the industry, emerging R&D initiatives between public and private sectors,the future of biotechnology under the Affordable Care Act (ACA) and the future of deal-making and global innovation.
|
|
BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization ActFeb 28 2013
BIO lauds the Senate for passing H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), yesterday by a unanimous vote. |
|
2013 BIO International Convention to Host Orphan Disease ForumFeb 28 2013
Forum to highlight new therapies and diagnosis for rare diseases, business models and partnering strategies for orphan drug products and commercialization of biologics for orphan indications and rare diseases
|
|
BIO Welcomes EPA Final Rule on New Advanced and Cellulosic BiofuelsFeb 26 2013
The U.S. Environmental Protection Agency issued long-awaited approval for advanced and cellulosic biofuels from camelina and energy cane, as well as renewable gasoline from previously approved biomass sources.
|
|
BIO World Congress to Address Industrial Biotech’s Role in Building a Biobased EconomyFeb 21 2013
The Biotechnology Industry Organization (BIO) announced its plenary session program for the 2013 World Congress on Industrial Biotechnology featuring biofuel and biobased product company executives, scientists and government officials from across the globe.
|
|
Farmers Increasingly Favor Biotech CropsFeb 20 2013
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420 million acres.
|
|
FDA Delay of Salmon Approval is a Blow to Science and BusinessFeb 13 2013
The U.S. Food and Drug Administration (FDA) announced today that it is extending for 60 days the comment period for the genetically engineered AquAdvantage Salmon.
|
|
International Program Spotlights the BRICs at the 2013 BIO International ConventionFeb 13 2013
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets and strategies for growing the global biotech industry
|
|
Innovation and The Supreme Court: Two Cases to WatchFeb 11 2013
An inside look at two cases facing the Supreme Court of the United States: Bowman v. Monsanto and Molecular Pathology v. Myriad Genetics.
|
